Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-c...
Saved in:
Published in | Blood Vol. 115; no. 6; pp. 1226 - 1237 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
Elsevier Inc
11.02.2010
Americain Society of Hematology American Society of Hematology |
Series | Lymphoid Neoplasia |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets. |
---|---|
AbstractList | Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets.Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets. Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA . Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations ( AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets. Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus-induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor alpha and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase-signal transducers and activators of transcription, and nuclear factor-kappaB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets. Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative genomic hybridization analyses. Compared with peripheral T-cell lymphoma, not otherwise specified, NKTCL had greater transcript levels for NK-cell and cytotoxic molecules, especially granzyme H. Compared with normal NKcells, tumors were closer to activated than resting cells and overexpressed several genes related to vascular biology, Epstein-Barr Virus–induced genes, and PDGFRA. Notably, platelet-derived growth factor receptor α and its phosphorylated form were confirmed at the protein level, and in vitro the MEC04 NKTCL cell line was sensitive to imatinib. Deregulation of the AKT, Janus kinase–signal transducers and activators of transcription, and nuclear factor-κB pathways was corroborated by nuclear expression of phosphorylated AKT, signal transducers and activators of transcription 3, and RelA in NKTCL, and several deregulated genes in these pathways mapped to regions of recurrent copy number aberrations (AKT3 [1q44], IL6R [1q21.3], CCL2 [17q12], TNFRSF21 [6p12.3]). Several features of NKTCL uncovered by this analysis suggest perturbation of angiogenic pathways. Integrative analysis also evidenced deregulation of the tumor suppressor HACE1 in the frequently deleted 6q21 region. This study highlights emerging oncogenic pathways in NKTCL and identifies novel diagnostic and therapeutic targets. |
Author | Marafioti, Teresa Bosq, Jacques Coppo, Paul de Leval, Laurence Delfau-Larue, Marie-Hélène Ghazi, Bouchra Martin-Garcia, Nadine Schmitt, Christian de Reyniès, Aurélien Petit, Barbara Emile, Jean-François Huang, Yenlin Gaulard, Philippe Travert, Marion Thomas, Emilie Brière, Josette |
Author_xml | – sequence: 1 givenname: Yenlin surname: Huang fullname: Huang, Yenlin organization: Inserm U955, Créteil, France – sequence: 2 givenname: Aurélien surname: de Reyniès fullname: de Reyniès, Aurélien organization: Ligue Nationale Contre le Cancer, Paris, France – sequence: 3 givenname: Laurence surname: de Leval fullname: de Leval, Laurence organization: Pathology Department, Centre Hospitalo-Universitaire (CHU) Sart Tilman, University of Liège, Liège, Belgium – sequence: 4 givenname: Bouchra surname: Ghazi fullname: Ghazi, Bouchra organization: Inserm U976, Hôpital Saint-Louis, Paris, France – sequence: 5 givenname: Nadine surname: Martin-Garcia fullname: Martin-Garcia, Nadine organization: Inserm U955, Créteil, France – sequence: 6 givenname: Marion surname: Travert fullname: Travert, Marion organization: Inserm U955, Créteil, France – sequence: 7 givenname: Jacques surname: Bosq fullname: Bosq, Jacques organization: Department of Medical Biology and Pathology, Institut Gustave Roussy, Villejuif, France – sequence: 8 givenname: Josette surname: Brière fullname: Brière, Josette organization: Inserm U728 et Service de Pathologie, Hôpital Saint-Louis, Paris, France – sequence: 9 givenname: Barbara surname: Petit fullname: Petit, Barbara organization: Département de Pathologie, CHU Dupuytren, Limoges, France – sequence: 10 givenname: Emilie surname: Thomas fullname: Thomas, Emilie organization: Ligue Nationale Contre le Cancer, Paris, France – sequence: 11 givenname: Paul surname: Coppo fullname: Coppo, Paul organization: Service d'Hématologie et de Thérapie Cellulaire, Hôpital Saint-Antoine and Université Pierre et Marie Curie, Paris, France – sequence: 12 givenname: Teresa surname: Marafioti fullname: Marafioti, Teresa organization: The Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom – sequence: 13 givenname: Jean-François surname: Emile fullname: Emile, Jean-François organization: Service de pathologie, Hôpital Ambroise Paré, AP-HP et EA4340, Université de Versailles, Saint-Quentin-en-Yvelines, France – sequence: 14 givenname: Marie-Hélène surname: Delfau-Larue fullname: Delfau-Larue, Marie-Hélène organization: Inserm U955, Créteil, France – sequence: 15 givenname: Christian surname: Schmitt fullname: Schmitt, Christian organization: Inserm U976, Hôpital Saint-Louis, Paris, France – sequence: 16 givenname: Philippe surname: Gaulard fullname: Gaulard, Philippe email: philippe.gaulard@hmn.aphp.fr organization: Inserm U955, Créteil, France |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22421456$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19965620$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UstuFDEQtFAQ2QT-AKG5IC4MaT_mxQEJRRAQEVzC2fJ4enaNPPZgexP27_FklxVwyMlSd1V1d7nOyInzDgl5TuENpS276K33Q8kAuhKqkjHKmuoRWdGKtSUAgxOyAoC6FF1DT8lZjD8AqOCsekJOadfVVc1gRe6u0GGBv-aAMRrvijn40Vjj1oUZ0CUzGowFThjWS8077dfojC5mlTZ3ahcLP2NQ6Z7gslAKyvlB2eLrl4ubUqO1hd1N88ZP6nXhVMydtJvxKXk8Khvx2eE9J98_fri5_FRef7v6fPn-utSiY6nkKIa6Exp5K5p8GqfQjhqHvm0Yb8au6qhq9AjItRItbxtFW9EjDrrXFQjOz8m7ve687adczicFZeUczKTCTnpl5L8dZzZy7W8la1nNuMgCrw4Cwf_cYkxyMnE5Szn02ygbzuuGCgYZ-eLvUccZf8zOgJcHgIpa2TE7pU084hgTjIqqzri3e5wOPsaAo9QmZYv9sqGxkoJcEiDvEyCXBEio5D4BmSz-Ix_3eJh28AnzZ9waDDJqgy5bbQLqJAdvHhb4Da7UzWU |
CitedBy_id | crossref_primary_10_1073_pnas_1520245113 crossref_primary_10_1097_CCO_0b013e32834b18ec crossref_primary_10_3389_fonc_2023_1240359 crossref_primary_10_1684_ejd_2018_3490 crossref_primary_10_3390_cancers15051366 crossref_primary_10_1038_s41419_023_05833_w crossref_primary_10_1097_PAS_0b013e318275d1a2 crossref_primary_10_1007_s00761_011_2126_5 crossref_primary_10_1007_s11899_014_0216_3 crossref_primary_10_1016_j_vetimm_2017_03_006 crossref_primary_10_3960_jslrt_20059 crossref_primary_10_1186_s13059_019_1651_1 crossref_primary_10_36829_63CTS_v8i2_948 crossref_primary_10_2174_1389450120666190227184654 crossref_primary_10_3892_or_2016_5205 crossref_primary_10_1186_s13000_022_01254_z crossref_primary_10_15252_embr_202356815 crossref_primary_10_1111_cas_15333 crossref_primary_10_1186_1746_1596_6_79 crossref_primary_10_3892_ol_2019_10139 crossref_primary_10_1016_j_leukres_2017_01_001 crossref_primary_10_3389_fonc_2019_00515 crossref_primary_10_1016_j_beha_2019_06_005 crossref_primary_10_1016_j_ajpath_2012_09_012 crossref_primary_10_1182_blood_2011_01_293050 crossref_primary_10_1007_s12263_012_0292_8 crossref_primary_10_3324_haematol_2023_282718 crossref_primary_10_1309_AJCP83AOQTMLOJTM crossref_primary_10_1111_his_15376 crossref_primary_10_1016_j_pathol_2024_07_002 crossref_primary_10_1038_onc_2014_316 crossref_primary_10_3109_10428194_2010_512964 crossref_primary_10_1007_s12253_011_9360_4 crossref_primary_10_1016_j_anndiagpath_2020_151623 crossref_primary_10_1517_13543784_2016_1121994 crossref_primary_10_3390_cancers13061414 crossref_primary_10_1111_j_1349_7006_2012_02321_x crossref_primary_10_1200_JOP_18_00719 crossref_primary_10_2217_epi_13_39 crossref_primary_10_3233_CBM_192437 crossref_primary_10_1016_j_beha_2012_01_004 crossref_primary_10_1515_med_2021_0409 crossref_primary_10_3390_cancers14030597 crossref_primary_10_3390_diagnostics12020409 crossref_primary_10_3390_cancers13236021 crossref_primary_10_1016_j_exphem_2012_08_005 crossref_primary_10_1182_blood_2022015646 crossref_primary_10_1007_s00277_019_03643_9 crossref_primary_10_1186_s13045_018_0678_1 crossref_primary_10_1186_s13046_015_0133_x crossref_primary_10_1016_j_humpath_2024_105650 crossref_primary_10_1111_1346_8138_12322 crossref_primary_10_1016_j_critrevonc_2021_103237 crossref_primary_10_1177_1010428317701648 crossref_primary_10_1016_j_prp_2015_12_010 crossref_primary_10_1038_s41467_018_03987_2 crossref_primary_10_1182_blood_2011_12_396150 crossref_primary_10_1016_j_canlet_2025_217602 crossref_primary_10_1038_s41379_021_00937_0 crossref_primary_10_1007_s12105_017_0802_5 crossref_primary_10_1007_s12105_016_0698_5 crossref_primary_10_1126_scitranslmed_3008970 crossref_primary_10_3109_10428194_2012_701293 crossref_primary_10_1371_journal_ppat_1008590 crossref_primary_10_1158_2643_3230_BCD_21_0098 crossref_primary_10_1016_S1470_2045_16_30148_6 crossref_primary_10_1182_blood_2012_06_438135 crossref_primary_10_1016_j_cdtm_2017_11_003 crossref_primary_10_1080_1062936X_2013_765912 crossref_primary_10_1002_ajh_23570 crossref_primary_10_1182_blood_2010_05_231548 crossref_primary_10_1172_JCI61205 crossref_primary_10_1097_CCO_0000000000000889 crossref_primary_10_1007_s11899_018_0460_z crossref_primary_10_1038_s41467_019_12032_9 crossref_primary_10_1097_PAS_0b013e31824433d8 crossref_primary_10_1007_s12185_023_03537_7 crossref_primary_10_1053_j_semdp_2016_11_003 crossref_primary_10_3892_ol_2019_10059 crossref_primary_10_1182_blood_2011_07_364364 crossref_primary_10_3109_10428194_2013_819577 crossref_primary_10_1002_path_2823 crossref_primary_10_5808_GI_2016_14_3_78 crossref_primary_10_1016_j_beha_2018_07_002 crossref_primary_10_1007_s11596_020_2250_9 crossref_primary_10_1038_leu_2017_40 crossref_primary_10_1038_s41375_022_01623_z crossref_primary_10_1158_1078_0432_CCR_14_1216 crossref_primary_10_1016_j_semcancer_2013_11_004 crossref_primary_10_3389_fonc_2023_1175545 crossref_primary_10_4049_jimmunol_1001682 crossref_primary_10_1371_journal_pone_0141906 crossref_primary_10_1038_cdd_2012_144 crossref_primary_10_1038_s41388_021_01680_1 crossref_primary_10_1186_s40164_020_00188_w crossref_primary_10_2174_1871520621666210908103306 crossref_primary_10_3390_cancers14102483 crossref_primary_10_3109_10428194_2010_543718 crossref_primary_10_3748_wjg_v26_i27_3989 crossref_primary_10_1016_j_exphem_2023_11_006 crossref_primary_10_1038_modpathol_2015_85 crossref_primary_10_1182_blood_2011_07_364224 crossref_primary_10_7889_hct_3_1 crossref_primary_10_1186_s13045_023_01483_9 crossref_primary_10_1016_j_ctrv_2020_102065 crossref_primary_10_3748_wjg_v26_i27_3985 crossref_primary_10_1053_j_semdp_2011_02_007 crossref_primary_10_1007_s11899_012_0136_z crossref_primary_10_3892_ol_2014_2509 crossref_primary_10_18632_oncotarget_3776 crossref_primary_10_1186_s13045_022_01293_5 crossref_primary_10_1038_leu_2010_255 crossref_primary_10_1182_blood_2012_08_450494 crossref_primary_10_1038_leu_2011_81 crossref_primary_10_1182_asheducation_2011_1_336 crossref_primary_10_1097_PPO_0b013e31821828b7 crossref_primary_10_1586_ehm_11_55 crossref_primary_10_1186_s13046_017_0601_6 crossref_primary_10_1371_journal_pone_0174136 crossref_primary_10_1016_j_ijrobp_2013_12_005 crossref_primary_10_1038_ng_3358 crossref_primary_10_3322_caac_21589 crossref_primary_10_1038_leu_2016_49 crossref_primary_10_1016_j_omto_2022_04_012 crossref_primary_10_1111_bjh_15702 crossref_primary_10_1002_hon_2588 crossref_primary_10_4143_crt_2023_1042 crossref_primary_10_1073_pnas_1115128108 crossref_primary_10_1007_s11912_017_0582_9 crossref_primary_10_1126_sciadv_aav2249 crossref_primary_10_1016_j_ijrobp_2010_10_040 crossref_primary_10_1080_10428194_2019_1654096 crossref_primary_10_1016_j_beha_2013_04_006 crossref_primary_10_1016_j_canlet_2012_12_022 crossref_primary_10_1053_j_seminhematol_2013_11_003 crossref_primary_10_18632_oncotarget_25835 crossref_primary_10_2217_ijh_14_21 crossref_primary_10_1186_s13045_019_0716_7 crossref_primary_10_1182_blood_2013_11_536359 crossref_primary_10_1016_j_tips_2010_12_005 crossref_primary_10_1016_j_blre_2015_08_003 crossref_primary_10_1182_blood_2013_01_453233 crossref_primary_10_1053_j_seminhematol_2022_10_002 crossref_primary_10_3390_cancers14215458 crossref_primary_10_3390_ijms19071931 crossref_primary_10_3390_cancers13225627 crossref_primary_10_1002_hon_2362 crossref_primary_10_1182_blood_2014_07_584953 crossref_primary_10_1051_medsci_20153111017 crossref_primary_10_1186_s12885_021_08695_7 crossref_primary_10_1016_j_leukres_2011_07_027 crossref_primary_10_1097_CCO_0b013e3283556142 crossref_primary_10_1007_s00277_024_05698_9 crossref_primary_10_1155_2011_790871 crossref_primary_10_3390_life12010073 crossref_primary_10_3892_etm_2017_4850 crossref_primary_10_1007_s12185_010_0738_y crossref_primary_10_1016_S1470_2045_16_30205_4 crossref_primary_10_3390_cancers12102900 crossref_primary_10_1007_s12185_017_2192_6 crossref_primary_10_1016_j_pathol_2019_09_011 crossref_primary_10_1002_bmm2_12128 crossref_primary_10_1097_CCO_0b013e328349aba6 crossref_primary_10_1038_s41467_024_52826_0 crossref_primary_10_3389_fonc_2020_00223 crossref_primary_10_1080_17474086_2019_1660640 crossref_primary_10_1002_advs_202303913 crossref_primary_10_1007_s11899_015_0289_7 crossref_primary_10_1080_10428194_2018_1480772 crossref_primary_10_1080_07357907_2017_1405016 crossref_primary_10_1016_j_ccell_2020_02_005 crossref_primary_10_1097_CM9_0000000000003152 crossref_primary_10_1371_journal_pone_0091521 crossref_primary_10_1186_s13045_017_0452_9 crossref_primary_10_1111_j_1365_2141_2011_08651_x crossref_primary_10_1016_j_mehy_2012_09_003 crossref_primary_10_1016_j_exphem_2021_12_191 crossref_primary_10_1155_2010_345053 crossref_primary_10_1186_s12943_023_01767_1 crossref_primary_10_1080_17474086_2016_1206465 crossref_primary_10_1155_2019_4860268 crossref_primary_10_3109_10428194_2013_813505 crossref_primary_10_1155_2015_435423 crossref_primary_10_3109_10428194_2011_645209 crossref_primary_10_1038_srep23695 crossref_primary_10_1002_adfm_202009946 crossref_primary_10_1182_blood_2011_04_346890 crossref_primary_10_1002_eji_201141870 crossref_primary_10_1016_j_prp_2014_02_004 crossref_primary_10_1038_leu_2014_50 crossref_primary_10_1186_s13046_017_0639_5 crossref_primary_10_1200_JCO_2011_40_7098 crossref_primary_10_1360_SSV_2024_0178 crossref_primary_10_3389_fonc_2023_1202964 crossref_primary_10_1007_s12032_014_0071_z crossref_primary_10_3389_fonc_2019_00386 crossref_primary_10_1053_j_semdp_2021_03_004 crossref_primary_10_1111_j_1751_553X_2011_01374_x crossref_primary_10_3390_hemato3030034 crossref_primary_10_3389_fped_2018_00405 crossref_primary_10_1038_s41598_021_89754_8 crossref_primary_10_1186_s12935_021_02296_x crossref_primary_10_1200_JCO_2016_71_7603 crossref_primary_10_18632_oncotarget_24698 crossref_primary_10_1053_j_semdp_2019_08_001 crossref_primary_10_3892_or_2012_2055 crossref_primary_10_1016_j_humpath_2018_08_025 crossref_primary_10_1146_annurev_pathol_020117_043821 crossref_primary_10_1155_2017_3724017 crossref_primary_10_1007_s11899_010_0062_x crossref_primary_10_1111_imr_12248 crossref_primary_10_1186_s13000_018_0765_1 crossref_primary_10_1111_j_1365_2559_2010_03704_x crossref_primary_10_1111_his_12596 crossref_primary_10_1016_j_molimm_2010_04_020 crossref_primary_10_1186_s12885_021_09023_9 crossref_primary_10_1002_hon_2459 crossref_primary_10_3389_fonc_2023_1235711 crossref_primary_10_1186_1756_9966_33_7 crossref_primary_10_1177_1479164120942119 crossref_primary_10_1182_blood_2014_07_588970 crossref_primary_10_1016_j_humpath_2012_02_007 crossref_primary_10_1182_blood_2023021787 crossref_primary_10_1038_leu_2013_157 crossref_primary_10_1097_PAS_0000000000000365 crossref_primary_10_1007_s12185_014_1521_2 crossref_primary_10_1016_j_ajpath_2014_07_011 crossref_primary_10_1016_j_bbrc_2018_08_181 crossref_primary_10_1016_j_yexmp_2017_06_008 |
Cites_doi | 10.1200/JCO.2008.18.5678 10.1038/sj.onc.1209301 10.1186/1471-2105-9-303 10.1177/106689690401200410 10.1038/nm1621 10.1182/blood.V95.11.3628 10.1182/blood-2006-07-025809 10.1172/JCI26833 10.1182/blood-2006-07-033142 10.1309/PNXUKA1CFJMVGCN1 10.1038/sj.bjc.6602968 10.1016/j.cancergencyto.2005.06.025 10.1002/path.2466 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1 10.1038/nri1995 10.1182/blood.V97.3.708 10.1038/leu.2009.3 10.1186/1471-2407-7-229 10.1002/cyto.1069 10.1074/jbc.M312481200 10.1038/sj.onc.1205571 10.1101/gad.1653708 10.1002/ijc.23432 10.1016/S0002-9440(10)65454-5 10.1007/s00277-008-0539-z 10.1016/S0002-9440(10)62340-1 10.1016/S0002-9440(10)63061-1 10.1046/j.1365-2141.2003.04419.x 10.4049/jimmunol.181.2.1001 10.1038/leu.2009.91 10.1186/1471-2164-8-230 10.1002/gcc.20245 10.1182/blood-2002-09-2908 10.1158/1078-0432.CCR-07-4102 10.1016/S0002-9440(10)65667-2 10.1084/jem.20090528 10.1182/blood-2006-10-055145 10.1038/nrd2530 10.1128/JVI.76.20.10427-10436.2002 10.1200/JCO.2008.16.4558 10.1038/sj.leu.2401246 10.1182/blood-2006-10-051649 10.1182/blood-2003-01-0295 10.1182/blood.V90.10.4099 10.1038/nature07968 10.4049/jimmunol.0804272 10.1038/84867 10.1182/blood-2005-05-2056 |
ContentType | Journal Article |
Copyright | 2010 American Society of Hematology 2015 INIST-CNRS 2010 by The American Society of Hematology |
Copyright_xml | – notice: 2010 American Society of Hematology – notice: 2015 INIST-CNRS – notice: 2010 by The American Society of Hematology |
DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1182/blood-2009-05-221275 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology Anatomy & Physiology |
EISSN | 1528-0020 |
EndPage | 1237 |
ExternalDocumentID | PMC2826234 19965620 22421456 10_1182_blood_2009_05_221275 S0006497120492547 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 0R~ 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. 6J9 9M8 AAEDW AAFTH AAXUO ABOCM ABVKL ACGFO ADBBV AENEX AFFNX AFOSN AKRWK ALMA_UNASSIGNED_HOLDINGS AQVPL BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 IH2 K-O KQ8 L7B LSO MJL N4W N9A OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV ZA5 AALRI AAYXX ACVFH ADCNI ADVLN AEUPX AFPUW AGCQF AIGII AITUG AKBMS AKYEP AMRAJ CITATION H13 .GJ AAQQT AAYWO AFETI AI. C1A EFKBS IQODW J5H MVM OHT VH1 WHG ZGI ZXP CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c492t-3e4d694ce38471523108fcedb87237f9591a7cf0e3ca48387a184beedcbc50433 |
ISSN | 0006-4971 1528-0020 |
IngestDate | Thu Aug 21 18:18:19 EDT 2025 Mon Jul 21 10:51:39 EDT 2025 Thu Apr 03 06:53:37 EDT 2025 Mon Jul 21 09:16:34 EDT 2025 Tue Jul 01 04:18:20 EDT 2025 Thu Apr 24 22:59:46 EDT 2025 Mon Apr 15 04:49:54 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Nose disease Hematology Lymphoproliferative syndrome ENT disease Nasal NK/T cell lymphoma Malignant hemopathy Non Hodgkin lymphoma Carcinogenesis Cancer Gene expression profile |
Language | English |
License | This article is made available under the Elsevier license. CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c492t-3e4d694ce38471523108fcedb87237f9591a7cf0e3ca48387a184beedcbc50433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Y.H. and A.d.R. contributed equally to this work. |
OpenAccessLink | https://dx.doi.org/10.1182/blood-2009-05-221275 |
PMID | 19965620 |
PQID | 733671420 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2826234 proquest_miscellaneous_733671420 pubmed_primary_19965620 pascalfrancis_primary_22421456 crossref_citationtrail_10_1182_blood_2009_05_221275 crossref_primary_10_1182_blood_2009_05_221275 elsevier_sciencedirect_doi_10_1182_blood_2009_05_221275 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-02-11 |
PublicationDateYYYYMMDD | 2010-02-11 |
PublicationDate_xml | – month: 02 year: 2010 text: 2010-02-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationSeriesTitle | Lymphoid Neoplasia |
PublicationTitle | Blood |
PublicationTitleAlternate | Blood |
PublicationYear | 2010 |
Publisher | Elsevier Inc Americain Society of Hematology American Society of Hematology |
Publisher_xml | – name: Elsevier Inc – name: Americain Society of Hematology – name: American Society of Hematology |
References | Compagno, Lim, Grunn (bib21) 2009; 459 Coppo, Gouilleux-Gruart, Huang (bib17) 2009; 23 Taborelli, Tibiletti, Martin, Pozzi, Bertoni, Capella (bib40) 2006; 165 Jost, Ruland (bib48) 2007; 109 Lin, Chen, Chuang, Liu, Hsu (bib14) 2003; 102 Carter, Cahir-McFarland, Kieff (bib30) 2002; 76 Kim, Park, Lee (bib8) 2005; 106 Schmitz, Hansmann, Bohle (bib50) 2009; 206 Swerdlow SH, Campo E, Harris NL, et al, WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues., 2008, Lyon, International Agency of Research on Cancer (IARC). Chanudet, Ye, Ferry (bib49) 2009; 217 Kuo, Shih, Tsang (bib7) 2004; 12 Vose, Armitage, Weisenburger (bib10) 2008; 26 de Reyniès, Assie, Rickman (bib22) 2009; 27 Zhang, Ohyashiki, Takaku, Shimizu, Ohyashiki (bib15) 2006; 94 Larousserie, Bardel, Pflanz (bib24) 2005; 166 Ko, Choi, Han, Kim, Ree (bib4) 2001; 46 Yamaguchi, Kita, Miwa (bib13) 1995; 76 de Leval, Rickman, Thielen (bib18) 2007; 109 Piccaluga, Agostinelli, Califano (bib34) 2007; 117 Bossard, Belhadj, Reyes (bib9) 2007; 109 Takakuwa, Dong, Nakatsuka (bib11) 2002; 21 Teruya-Feldstein, Jaffe, Burd (bib39) 1997; 90 Dybkaer, Iqbal, Zhou (bib19) 2007; 8 Krenacs, Smyth, Bagdi (bib37) 2003; 101 Comoglio, Giordano, Trusolino (bib44) 2008; 7 Chow, Liu, Chan, Lei, Chan, Lo (bib45) 2005; 90 Rouget-Quermalet, Giustiniani, Marie-Cardine (bib31) 2006; 25 Feldman, Law, Grogg (bib6) 2008; 130 Toepoel, Joosten, Knobbe (bib29) 2008; 123 Boulland, Meignin, Leroy-Viard (bib47) 1998; 153 Yu, Kortylewski, Pardoll (bib32) 2007; 7 Tabone-Eglinger, Subra, El Sayadi (bib28) 2008; 14 Nagata, Konno, Kimura (bib16) 2001; 97 Pongers-Willemse, Verhagen, Tibbe (bib27) 1998; 12 Siu, Wong, Chan, Kwong (bib41) 1999; 155 Fellows, Gil-Parrado, Jenne, Kurschus (bib38) 2007; 110 Sakata, Someya, Omatsu (bib46) 2007; 7 Zhang, Anglesio, O'Sullivan (bib43) 2007; 13 Chen, Chang, Su, Chen (bib35) 2008; 87 Caron, Le Gallou, Lamy, Tarte, Fest (bib20) 2009; 182 Haedicke, Ho, Chott (bib2) 2000; 95 Joosten, Toepoel, Mariman, Van Zoelen (bib36) 2001; 27 Iqbal, Kucuk, Deleeuw (bib5) 2009; 23 Travert, Ame-Thomas, Pangault (bib26) 2008; 181 Sedelies, Sayers, Edwards (bib25) 2004; 279 Quintanilla-Martinez, Kremer, Keller (bib12) 2001; 159 Andrae, Gallini, Betsholtz (bib33) 2008; 22 Strimmer (bib23) 2008; 9 Sun, Su, Lin, Chen, Fang (bib42) 2003; 122 Nakashima, Tagawa, Suzuki (bib3) 2005; 44 Sedelies (2019111800233829100_B25) 2004; 279 Sun (2019111800233829100_B42) 2003; 122 Travert (2019111800233829100_B26) 2008; 181 Kuo (2019111800233829100_B7) 2004; 12 Quintanilla-Martinez (2019111800233829100_B12) 2001; 159 Dybkaer (2019111800233829100_B19) 2007; 8 Nagata (2019111800233829100_B16) 2001; 97 Chen (2019111800233829100_B35) 2008; 87 Kim (2019111800233829100_B8) 2005; 106 Joosten (2019111800233829100_B36) 2001; 27 Toepoel (2019111800233829100_B29) 2008; 123 Fellows (2019111800233829100_B38) 2007; 110 Chanudet (2019111800233829100_B49) 2009; 217 Bossard (2019111800233829100_B9) 2007; 109 Rouget-Quermalet (2019111800233829100_B31) 2006; 25 Zhang (2019111800233829100_B43) 2007; 13 Coppo (2019111800233829100_B17) 2009; 23 Compagno (2019111800233829100_B21) 2009; 459 Teruya-Feldstein (2019111800233829100_B39) 1997; 90 Sakata (2019111800233829100_B46) 2007; 7 Tabone-Eglinger (2019111800233829100_B28) 2008; 14 Haedicke (2019111800233829100_B2) 2000; 95 Zhang (2019111800233829100_B15) 2006; 94 Piccaluga (2019111800233829100_B34) 2007; 117 Nakashima (2019111800233829100_B3) 2005; 44 Comoglio (2019111800233829100_B44) 2008; 7 Schmitz (2019111800233829100_B50) 2009; 206 Iqbal (2019111800233829100_B5) 2009; 23 Pongers-Willemse (2019111800233829100_B27) 1998; 12 Andrae (2019111800233829100_B33) 2008; 22 Boulland (2019111800233829100_B47) 1998; 153 Larousserie (2019111800233829100_B24) 2005; 166 Lin (2019111800233829100_B14) 2003; 102 Swerdlow (2019111800233829100_B1) 2008 Taborelli (2019111800233829100_B40) 2006; 165 Carter (2019111800233829100_B30) 2002; 76 Vose (2019111800233829100_B10) 2008; 26 Yu (2019111800233829100_B32) 2007; 7 Takakuwa (2019111800233829100_B11) 2002; 21 Siu (2019111800233829100_B41) 1999; 155 de Reyniès (2019111800233829100_B22) 2009; 27 Yamaguchi (2019111800233829100_B13) 1995; 76 Feldman (2019111800233829100_B6) 2008; 130 Strimmer (2019111800233829100_B23) 2008; 9 Caron (2019111800233829100_B20) 2009; 182 Jost (2019111800233829100_B48) 2007; 109 Chow (2019111800233829100_B45) 2005; 90 de Leval (2019111800233829100_B18) 2007; 109 Krenacs (2019111800233829100_B37) 2003; 101 Ko (2019111800233829100_B4) 2001; 46 |
References_xml | – volume: 153 start-page: 1229 year: 1998 end-page: 1237 ident: bib47 article-title: Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas publication-title: Am J Pathol – volume: 27 start-page: 1108 year: 2009 end-page: 1115 ident: bib22 article-title: Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival publication-title: J Clin Oncol – volume: 76 start-page: 2351 year: 1995 end-page: 2356 ident: bib13 article-title: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells publication-title: Cancer – volume: 12 start-page: 2006 year: 1998 end-page: 2014 ident: bib27 article-title: Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes publication-title: Leukemia – volume: 97 start-page: 708 year: 2001 end-page: 713 ident: bib16 article-title: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus publication-title: Blood – reference: Swerdlow SH, Campo E, Harris NL, et al, WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues., 2008, Lyon, International Agency of Research on Cancer (IARC). – volume: 94 start-page: 599 year: 2006 end-page: 608 ident: bib15 article-title: Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection publication-title: Br J Cancer – volume: 7 start-page: 41 year: 2007 end-page: 51 ident: bib32 article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment publication-title: Nat Rev Immunol – volume: 459 start-page: 717 year: 2009 end-page: 721 ident: bib21 article-title: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma publication-title: Nature – volume: 46 start-page: 85 year: 2001 end-page: 91 ident: bib4 article-title: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma publication-title: Cytometry – volume: 9 start-page: 303 year: 2008 ident: bib23 article-title: A unified approach to false discovery rate estimation publication-title: BMC Bioinformatics – volume: 101 start-page: 3590 year: 2003 end-page: 3593 ident: bib37 article-title: The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity publication-title: Blood – volume: 23 start-page: 1667 year: 2009 end-page: 1678 ident: bib17 article-title: STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma publication-title: Leukemia – volume: 7 start-page: 504 year: 2008 end-page: 516 ident: bib44 article-title: Drug development of MET inhibitors: targeting oncogene addiction and expedience publication-title: Nat Rev Drug Discov – volume: 21 start-page: 4702 year: 2002 end-page: 4705 ident: bib11 article-title: Frequent mutations of Fas gene in nasal NK/T cell lymphoma publication-title: Oncogene – volume: 102 start-page: 2623 year: 2003 end-page: 2631 ident: bib14 article-title: CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma publication-title: Blood – volume: 25 start-page: 2807 year: 2006 end-page: 2811 ident: bib31 article-title: Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas publication-title: Oncogene – volume: 23 start-page: 1139 year: 2009 end-page: 1151 ident: bib5 article-title: Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies publication-title: Leukemia – volume: 159 start-page: 2095 year: 2001 end-page: 2105 ident: bib12 article-title: p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease publication-title: Am J Pathol – volume: 90 start-page: 4099 year: 1997 end-page: 4105 ident: bib39 article-title: The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease publication-title: Blood – volume: 206 start-page: 981 year: 2009 end-page: 989 ident: bib50 article-title: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma publication-title: J Exp Med – volume: 22 start-page: 1276 year: 2008 end-page: 1312 ident: bib33 article-title: Role of platelet-derived growth factors in physiology and medicine publication-title: Genes Dev – volume: 12 start-page: 375 year: 2004 end-page: 387 ident: bib7 article-title: Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities publication-title: Int J Surg Pathol – volume: 7 start-page: 229 year: 2007 ident: bib46 article-title: The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma publication-title: BMC Cancer – volume: 44 start-page: 247 year: 2005 end-page: 255 ident: bib3 article-title: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type publication-title: Genes Chromosomes Cancer – volume: 123 start-page: 322 year: 2008 end-page: 329 ident: bib29 article-title: Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas publication-title: Int J Cancer – volume: 106 start-page: 3785 year: 2005 end-page: 3790 ident: bib8 article-title: Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type publication-title: Blood – volume: 155 start-page: 1419 year: 1999 end-page: 1425 ident: bib41 article-title: Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations publication-title: Am J Pathol – volume: 26 start-page: 4124 year: 2008 end-page: 4130 ident: bib10 article-title: International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes publication-title: J Clin Oncol – volume: 110 start-page: 544 year: 2007 end-page: 552 ident: bib38 article-title: Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program publication-title: Blood – volume: 27 start-page: 215 year: 2001 end-page: 217 ident: bib36 article-title: Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects publication-title: Nat Genet – volume: 122 start-page: 590 year: 2003 end-page: 599 ident: bib42 article-title: A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma publication-title: Br J Haematol – volume: 8 start-page: 230 year: 2007 ident: bib19 article-title: Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways publication-title: BMC Genomics – volume: 95 start-page: 3628 year: 2000 end-page: 3630 ident: bib2 article-title: Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas publication-title: Blood – volume: 109 start-page: 2183 year: 2007 end-page: 2189 ident: bib9 article-title: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials publication-title: Blood – volume: 13 start-page: 1060 year: 2007 end-page: 1069 ident: bib43 article-title: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers publication-title: Nat Med – volume: 90 start-page: 274 year: 2005 end-page: 275 ident: bib45 article-title: AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type publication-title: Haematologica – volume: 130 start-page: 178 year: 2008 end-page: 185 ident: bib6 article-title: Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization publication-title: Am J Clin Pathol – volume: 14 start-page: 2285 year: 2008 end-page: 2294 ident: bib28 article-title: KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors publication-title: Clin Cancer Res – volume: 87 start-page: 985 year: 2008 end-page: 990 ident: bib35 article-title: The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas publication-title: Ann Hematol – volume: 217 start-page: 420 year: 2009 end-page: 430 ident: bib49 article-title: A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands publication-title: J Pathol – volume: 279 start-page: 26581 year: 2004 end-page: 26587 ident: bib25 article-title: Discordant regulation of granzyme H and granzyme B expression in human lymphocytes publication-title: J Biol Chem – volume: 76 start-page: 10427 year: 2002 end-page: 10436 ident: bib30 article-title: Epstein-Barr virus-induced changes in B-lymphocyte gene expression publication-title: J Virol – volume: 182 start-page: 7595 year: 2009 end-page: 7602 ident: bib20 article-title: CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells publication-title: J Immunol – volume: 109 start-page: 2700 year: 2007 end-page: 2707 ident: bib48 article-title: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications publication-title: Blood – volume: 109 start-page: 4952 year: 2007 end-page: 4963 ident: bib18 article-title: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells publication-title: Blood – volume: 166 start-page: 1217 year: 2005 end-page: 1228 ident: bib24 article-title: Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells publication-title: Am J Pathol – volume: 181 start-page: 1001 year: 2008 end-page: 1011 ident: bib26 article-title: CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL publication-title: J Immunol – volume: 165 start-page: 106 year: 2006 end-page: 113 ident: bib40 article-title: Chromosome band 6q deletion pattern in malignant lymphomas publication-title: Cancer Genet Cytogenet – volume: 117 start-page: 823 year: 2007 end-page: 834 ident: bib34 article-title: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets publication-title: J Clin Invest – volume: 27 start-page: 1108 issue: 7 year: 2009 ident: 2019111800233829100_B22 article-title: Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. publication-title: J Clin Oncol doi: 10.1200/JCO.2008.18.5678 – volume: 25 start-page: 2807 issue: 19 year: 2006 ident: 2019111800233829100_B31 article-title: Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. publication-title: Oncogene doi: 10.1038/sj.onc.1209301 – volume: 9 start-page: 303 year: 2008 ident: 2019111800233829100_B23 article-title: A unified approach to false discovery rate estimation. publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-9-303 – volume: 12 start-page: 375 issue: 4 year: 2004 ident: 2019111800233829100_B7 article-title: Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. publication-title: Int J Surg Pathol doi: 10.1177/106689690401200410 – volume: 90 start-page: 274 issue: 2 year: 2005 ident: 2019111800233829100_B45 article-title: AKT plays a role in the survival of the tumor cells of extranodal NK/T-cell lymphoma, nasal type. publication-title: Haematologica – volume: 13 start-page: 1060 issue: 9 year: 2007 ident: 2019111800233829100_B43 article-title: The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers. publication-title: Nat Med doi: 10.1038/nm1621 – volume: 95 start-page: 3628 issue: 11 year: 2000 ident: 2019111800233829100_B2 article-title: Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. publication-title: Blood doi: 10.1182/blood.V95.11.3628 – volume: 109 start-page: 2700 issue: 7 year: 2007 ident: 2019111800233829100_B48 article-title: Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. publication-title: Blood doi: 10.1182/blood-2006-07-025809 – volume: 117 start-page: 823 issue: 3 year: 2007 ident: 2019111800233829100_B34 article-title: Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. publication-title: J Clin Invest doi: 10.1172/JCI26833 – volume: 109 start-page: 2183 issue: 5 year: 2007 ident: 2019111800233829100_B9 article-title: Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. publication-title: Blood doi: 10.1182/blood-2006-07-033142 – volume: 130 start-page: 178 issue: 2 year: 2008 ident: 2019111800233829100_B6 article-title: Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization. publication-title: Am J Clin Pathol doi: 10.1309/PNXUKA1CFJMVGCN1 – volume: 94 start-page: 599 issue: 4 year: 2006 ident: 2019111800233829100_B15 article-title: Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. publication-title: Br J Cancer doi: 10.1038/sj.bjc.6602968 – volume: 165 start-page: 106 issue: 2 year: 2006 ident: 2019111800233829100_B40 article-title: Chromosome band 6q deletion pattern in malignant lymphomas. publication-title: Cancer Genet Cytogenet doi: 10.1016/j.cancergencyto.2005.06.025 – volume: 217 start-page: 420 issue: 3 year: 2009 ident: 2019111800233829100_B49 article-title: A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. publication-title: J Pathol doi: 10.1002/path.2466 – volume: 76 start-page: 2351 issue: 11 year: 1995 ident: 2019111800233829100_B13 article-title: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. publication-title: Cancer doi: 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1 – volume: 7 start-page: 41 issue: 1 year: 2007 ident: 2019111800233829100_B32 article-title: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. publication-title: Nat Rev Immunol doi: 10.1038/nri1995 – year: 2008 ident: 2019111800233829100_B1 article-title: WHO Classification of Tumours of the Haematopoietic and Lymphoid tissues. – volume: 97 start-page: 708 issue: 3 year: 2001 ident: 2019111800233829100_B16 article-title: Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. publication-title: Blood doi: 10.1182/blood.V97.3.708 – volume: 23 start-page: 1139 issue: 6 year: 2009 ident: 2019111800233829100_B5 article-title: Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies. publication-title: Leukemia doi: 10.1038/leu.2009.3 – volume: 7 start-page: 229 year: 2007 ident: 2019111800233829100_B46 article-title: The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma. publication-title: BMC Cancer doi: 10.1186/1471-2407-7-229 – volume: 46 start-page: 85 issue: 2 year: 2001 ident: 2019111800233829100_B4 article-title: Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma. publication-title: Cytometry doi: 10.1002/cyto.1069 – volume: 279 start-page: 26581 issue: 25 year: 2004 ident: 2019111800233829100_B25 article-title: Discordant regulation of granzyme H and granzyme B expression in human lymphocytes. publication-title: J Biol Chem doi: 10.1074/jbc.M312481200 – volume: 21 start-page: 4702 issue: 30 year: 2002 ident: 2019111800233829100_B11 article-title: Frequent mutations of Fas gene in nasal NK/T cell lymphoma. publication-title: Oncogene doi: 10.1038/sj.onc.1205571 – volume: 22 start-page: 1276 issue: 10 year: 2008 ident: 2019111800233829100_B33 article-title: Role of platelet-derived growth factors in physiology and medicine. publication-title: Genes Dev doi: 10.1101/gad.1653708 – volume: 123 start-page: 322 issue: 2 year: 2008 ident: 2019111800233829100_B29 article-title: Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas. publication-title: Int J Cancer doi: 10.1002/ijc.23432 – volume: 155 start-page: 1419 issue: 5 year: 1999 ident: 2019111800233829100_B41 article-title: Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia: recognition of consistent patterns of genetic alterations. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)65454-5 – volume: 87 start-page: 985 issue: 12 year: 2008 ident: 2019111800233829100_B35 article-title: The expression and prognostic significance of platelet-derived growth factor receptor alpha in mature T- and natural killer-cell lymphomas. publication-title: Ann Hematol doi: 10.1007/s00277-008-0539-z – volume: 166 start-page: 1217 issue: 4 year: 2005 ident: 2019111800233829100_B24 article-title: Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)62340-1 – volume: 159 start-page: 2095 issue: 6 year: 2001 ident: 2019111800233829100_B12 article-title: p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)63061-1 – volume: 122 start-page: 590 issue: 4 year: 2003 ident: 2019111800233829100_B42 article-title: A 2.6 Mb interval on chromosome 6q25.2-q25.3 is commonly deleted in human nasal natural killer/T-cell lymphoma. publication-title: Br J Haematol doi: 10.1046/j.1365-2141.2003.04419.x – volume: 181 start-page: 1001 issue: 2 year: 2008 ident: 2019111800233829100_B26 article-title: CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. publication-title: J Immunol doi: 10.4049/jimmunol.181.2.1001 – volume: 23 start-page: 1667 issue: 9 year: 2009 ident: 2019111800233829100_B17 article-title: STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma. publication-title: Leukemia doi: 10.1038/leu.2009.91 – volume: 8 start-page: 230 year: 2007 ident: 2019111800233829100_B19 article-title: Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways. publication-title: BMC Genomics doi: 10.1186/1471-2164-8-230 – volume: 44 start-page: 247 issue: 3 year: 2005 ident: 2019111800233829100_B3 article-title: Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type. publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20245 – volume: 101 start-page: 3590 issue: 9 year: 2003 ident: 2019111800233829100_B37 article-title: The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. publication-title: Blood doi: 10.1182/blood-2002-09-2908 – volume: 14 start-page: 2285 issue: 8 year: 2008 ident: 2019111800233829100_B28 article-title: KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors. publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-4102 – volume: 153 start-page: 1229 issue: 4 year: 1998 ident: 2019111800233829100_B47 article-title: Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)65667-2 – volume: 206 start-page: 981 issue: 5 year: 2009 ident: 2019111800233829100_B50 article-title: TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. publication-title: J Exp Med doi: 10.1084/jem.20090528 – volume: 109 start-page: 4952 issue: 11 year: 2007 ident: 2019111800233829100_B18 article-title: The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. publication-title: Blood doi: 10.1182/blood-2006-10-055145 – volume: 7 start-page: 504 issue: 6 year: 2008 ident: 2019111800233829100_B44 article-title: Drug development of MET inhibitors: targeting oncogene addiction and expedience. publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2530 – volume: 76 start-page: 10427 issue: 20 year: 2002 ident: 2019111800233829100_B30 article-title: Epstein-Barr virus-induced changes in B-lymphocyte gene expression. publication-title: J Virol doi: 10.1128/JVI.76.20.10427-10436.2002 – volume: 26 start-page: 4124 issue: 25 year: 2008 ident: 2019111800233829100_B10 article-title: International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. publication-title: J Clin Oncol doi: 10.1200/JCO.2008.16.4558 – volume: 12 start-page: 2006 issue: 12 year: 1998 ident: 2019111800233829100_B27 article-title: Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. publication-title: Leukemia doi: 10.1038/sj.leu.2401246 – volume: 110 start-page: 544 issue: 2 year: 2007 ident: 2019111800233829100_B38 article-title: Natural killer cell-derived human granzyme H induces an alternative, caspase-independent cell-death program. publication-title: Blood doi: 10.1182/blood-2006-10-051649 – volume: 102 start-page: 2623 issue: 7 year: 2003 ident: 2019111800233829100_B14 article-title: CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma. publication-title: Blood doi: 10.1182/blood-2003-01-0295 – volume: 90 start-page: 4099 issue: 10 year: 1997 ident: 2019111800233829100_B39 article-title: The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. publication-title: Blood doi: 10.1182/blood.V90.10.4099 – volume: 459 start-page: 717 issue: 7247 year: 2009 ident: 2019111800233829100_B21 article-title: Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. publication-title: Nature doi: 10.1038/nature07968 – volume: 182 start-page: 7595 issue: 12 year: 2009 ident: 2019111800233829100_B20 article-title: CXCR4 expression functionally discriminates centroblasts versus centrocytes within human germinal center B cells. publication-title: J Immunol doi: 10.4049/jimmunol.0804272 – volume: 27 start-page: 215 issue: 2 year: 2001 ident: 2019111800233829100_B36 article-title: Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects. publication-title: Nat Genet doi: 10.1038/84867 – volume: 106 start-page: 3785 issue: 12 year: 2005 ident: 2019111800233829100_B8 article-title: Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. publication-title: Blood doi: 10.1182/blood-2005-05-2056 |
SSID | ssj0014325 |
Score | 2.4669476 |
Snippet | Biopsies and cell lines of natural killer/T-cell lymphoma, nasal type (NKTCL) were subject to combined gene expression profiling and array-based comparative... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1226 |
SubjectTerms | Adult Aged Biological and medical sciences Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Blotting, Western Cell Proliferation Cells, Cultured Comparative Genomic Hybridization Epstein-Barr Virus Infections - genetics Epstein-Barr Virus Infections - metabolism Epstein-Barr Virus Infections - virology Female Gene Expression Profiling Hematologic and hematopoietic diseases Herpesvirus 4, Human - physiology Humans Immunoenzyme Techniques Killer Cells, Natural - pathology Killer Cells, Natural - virology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoid Neoplasia Lymphoma, Extranodal NK-T-Cell - genetics Lymphoma, Extranodal NK-T-Cell - metabolism Lymphoma, Extranodal NK-T-Cell - virology Male Medical sciences Middle Aged Nasal Mucosa - metabolism Nasal Mucosa - pathology Nasopharyngeal Neoplasms - genetics Nasopharyngeal Neoplasms - metabolism Nasopharyngeal Neoplasms - virology Oligonucleotide Array Sequence Analysis Oncogenes - physiology Receptors, Platelet-Derived Growth Factor - genetics Receptors, Platelet-Derived Growth Factor - metabolism Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics RNA, Messenger - metabolism Signal Transduction Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism |
Title | Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type |
URI | https://dx.doi.org/10.1182/blood-2009-05-221275 https://www.ncbi.nlm.nih.gov/pubmed/19965620 https://www.proquest.com/docview/733671420 https://pubmed.ncbi.nlm.nih.gov/PMC2826234 |
Volume | 115 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZxz5gjC3dR_ZR9DD20rl1JDuSH9uyrSxbYNBC92QcWSaGxA5NQkn_gv3Zu5Pkj2wp3fZijC3Lxvfz-U539ztC3nHNeaIUeCeh9sFBCXzQg4OBx1M_0plWXGiT5TsanJ4HXy7Ci07nZytrabUcH6jrrXUl_yNVOAZyxSrZf5BsPSkcgH2QL2xBwrD9KxkjZzRy9NtcVpNsleWmvjxPbRaQXuxjBbDtRFSoEqbKFZKpTq6S9WK_nCOnsitrATUNP64yBaGNhkgq4uGq_v50DQIvZ8bILJIFJqeD77oRDJ66jvMWH24F-geuk9TQS7E_xLrITWBe2hbIKxemBzO4Pe4rMpBXNdu6BcrPk-TaJB8clys1uUzaKxYYbGee06jaaVmkxfaZv6GGbVmnw1tbqfaZLar_U9tLZI-1Gf42yhN6zFDWt4eDzOYzgwDMuAZ7z2_-fXVGYnXqDrnLwOHAXhjD7008KuAsdIWXcNPDbbc09LN2kptsnEfzZAFfXmZbpmzzaX5PzW3ZOmdPyGPnpNAji7inpKOLLtk9KpJlOVvT99SkDZt4TJfcO672HpxUzQO75P43l7OxS64QpbRBKa1RShuU0gqltEYprVBKa5TSvKANSuloeGgxSiuMfqAGoRQR-oycf_p4dnLquXYfngoitvS4DtJBFCjN0WIK0fGQmdLpWArGRRaFUT8RKvM1RyZ-LkXSl8EYbDw1VoaH7znZKcpCvyRUSj2QKot4GIggVDqRfZGBLzyIUl-ISPQIrwQUK8eFjy1ZprHxiSWLjYSxR2sU-2FsJdwjXn3V3HLB3DJeVLKPnT1r7dQYAHzLlXsbUKlvxzCDA3yeHqEVdmKQLL7qpNDlahEjvanoB8zvkRcWSs2zOnjCc22ArB6AVPObZ4p8YijnmWTgJwWvbpzzNXnYfOpvyM7ycqXfgrm-HO-ZL-kXNgnq5w |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene+expression+profiling+identifies+emerging+oncogenic+pathways+operating+in+extranodal+NK%2FT-cell+lymphoma%2C+nasal+type&rft.jtitle=Blood&rft.au=Huang%2C+Yenlin&rft.au=de+Reyni%C3%A8s%2C+Aur%C3%A9lien&rft.au=de+Leval%2C+Laurence&rft.au=Ghazi%2C+Bouchra&rft.date=2010-02-11&rft.eissn=1528-0020&rft.volume=115&rft.issue=6&rft.spage=1226&rft_id=info:doi/10.1182%2Fblood-2009-05-221275&rft_id=info%3Apmid%2F19965620&rft.externalDocID=19965620 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |